Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerie Waters

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Current Pharmaceutical Design|January 11, 2012
New treatments for emerging cystic fibrosis pathogens other than PseudomonasValerie Waters
American Journal of Respiratory and Critical Care Medicine|September 20, 2021
Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary ExacerbationsValerie Waters
Annals of the American Thoracic Society|June 2, 2018
Chronic Antibiotic Use in Cystic Fibrosis: A Fine BalanceValerie Waters
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2014
Editorial commentary: how can understanding the phenotype of Pseudomonas aeruginosa lead to more successful eradication strategies in cystic fibrosis?Valerie Waters
The Cochrane Database of Systematic Reviews|November 3, 2015
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosisValerie Waters, Felix Ratjen
The Pediatric Infectious Disease Journal|March 18, 2016
Infections With Biofilm Formation: Selection of Antimicrobials and Role of Prolonged Antibiotic TherapyTrevor Beaudoin, Valerie Waters
The Cochrane Database of Systematic Reviews|October 6, 2017
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisValerie Waters, Felix Ratjen
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 1, 2018
Defining chronic Pseudomonas aeruginosa infection in cystic fibrosisValerie Waters, Keith Grimwood
Annals of the American Thoracic Society|November 24, 2015
Pulmonary Exacerbations in Children with Cystic FibrosisValerie Waters, Felix Ratjen
Expert Review of Respiratory Medicine|June 3, 2014
Inhaled liposomal amikacinValerie Waters, Felix Ratjen
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Current Pharmaceutical Design|January 11, 2012
New treatments for emerging cystic fibrosis pathogens other than PseudomonasValerie Waters
American Journal of Respiratory and Critical Care Medicine|September 20, 2021
Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary ExacerbationsValerie Waters
Annals of the American Thoracic Society|June 2, 2018
Chronic Antibiotic Use in Cystic Fibrosis: A Fine BalanceValerie Waters
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2014
Editorial commentary: how can understanding the phenotype of Pseudomonas aeruginosa lead to more successful eradication strategies in cystic fibrosis?Valerie Waters
The Cochrane Database of Systematic Reviews|November 3, 2015
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosisValerie Waters, Felix Ratjen
The Pediatric Infectious Disease Journal|March 18, 2016
Infections With Biofilm Formation: Selection of Antimicrobials and Role of Prolonged Antibiotic TherapyTrevor Beaudoin, Valerie Waters
The Cochrane Database of Systematic Reviews|October 6, 2017
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisValerie Waters, Felix Ratjen
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 1, 2018
Defining chronic Pseudomonas aeruginosa infection in cystic fibrosisValerie Waters, Keith Grimwood
Annals of the American Thoracic Society|November 24, 2015
Pulmonary Exacerbations in Children with Cystic FibrosisValerie Waters, Felix Ratjen
Expert Review of Respiratory Medicine|June 3, 2014
Inhaled liposomal amikacinValerie Waters, Felix Ratjen
Pageof 12